gearinjectuk.com
No products in the cart.
Return To Shopgearinjectuk.com
No products in the cart.
Return To ShopWhen seeking quality performance-enhancing medications, Aprezo 30 mg from Glenmark Pharmaceuticals Ltd. stands out as a reliable option. Available at competitive prices, this product is designed for athletes and bodybuilders who wish to optimize their performance safely and effectively. Buying Aprezo from our platform guarantees both affordability and authenticity, ensuring that you receive the genuine article without overpaying. Our commitment to customer satisfaction, secure payment methods, and swift shipping make us the go-to choice for sports pharmacology products.
Aprezo 30 mg is a pharmaceutical formulation primarily composed of Apremilast, a selective inhibitor of phosphodiesterase-4 (PDE4). This medication is well-known for its role in regulating inflammatory cytokines, making it a potential tool for athletes concerned with recovery and overall well-being. Each tablet contains 30 mg of Apremilast and various excipients that facilitate absorption and bioavailability.
The primary activity of Aprezo revolves around its anti-inflammatory properties, which are particularly beneficial in managing conditions like arthritis. However, its potential extends to sports pharmacology, where it may aid athletes in enhancing recovery and reducing the risk of injury caused by inflammation.
Aprezo works by inhibiting the action of phosphodiesterase-4, leading to an increase in intracellular cyclic adenosine monophosphate (cAMP) levels. This process alters the activity of various inflammatory pathways, effectively downregulating the release of pro-inflammatory cytokines. By doing this, Aprezo reduces inflammation, which is critical in sports and exercise recovery.
In a competitive environment where muscle fatigue and injuries can hinder performance, the biological effect of Aprezo can be significant. By lessening inflammation and possibly promoting faster recovery, athletes may find themselves better equipped to train harder and more frequently, leading to improved performance metrics.
The integration of Aprezo into sports pharmacology has yielded promising results. Athletes using Aprezo have reported reduced muscle soreness post-training, enhanced endurance, and quicker recovery times. These benefits enable athletes to train with greater intensity and frequency, ultimately leading to improved performance in competitions.
Clinical studies have indicated that the anti-inflammatory properties of Aprezo can lead to better muscle repair and regeneration. Improved recovery times mean athletes can return to their training regimens faster, minimizing downtime due to injury or fatigue. As a result, this can translate into performance improvements, making Aprezo a sound choice for athletes who prioritize both physical output and long-term health.
While Aprezo is generally considered safe for many users, athletes should be aware of potential contraindications and side effects. Common side effects may include nausea, diarrhea, and headache. It’s crucial for individuals to consult healthcare professionals before starting Aprezo to ensure that it aligns with their medical history and current medications.
Here are some recommendations for safe usage:
In summary, Aprezo 30 mg Glenmark Pharmaceuticals Ltd. offers athletes a powerful tool for managing inflammation and enhancing recovery. With the right precautions, it can be a beneficial addition to training regimens aimed at maximized performance.
| Active substance | Apremilast |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | Minimal to no hepatotoxicity reported |
| Lab Test | Monitoring is not typically required for liver enzymes unless under specific medical advice |
| Strength | 30mg |
| Also known as | CC-10004 |
| Blood pressure | No significant effects on blood pressure |
| Trade name | Otezla |
| Storage conditions | Store at 20В°C to 25В°C (68В°F to 77В°F), excursions permitted between 15В°C to 30В°C (59В°F to 86В°F) |
| Chemical name | N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide |
| Formula | C22H24N2O7S |
| Substance class | Phosphodiesterase 4 (PDE4) inhibitor |
| Main action | Anti-inflammatory |
| Half-life | Approximately 6-9 hours |
| Dosage (medical) | 30 mg twice daily after initial titration |
| Dosage (sports) | Not applicable |
| Effects | Reduces inflammation by inhibiting PDE4, an enzyme involved in the process of inflammatory response |
| Side effects | Diarrhea, nausea, headache, upper respiratory tract infection, weight loss |
| Use in sports | Not typically used in sports, lacks performance-enhancing properties |
| Manufacturer | Glenmark Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
€8.00
€26.00
Reviews
There are no reviews yet.